Epidemiology of Dementia in China in 2010-2020: A Systematic Review and Meta-Analysis. 2024

Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
School of Nursing, Nanjing Medical University, Nanjing 210029, China.

BACKGROUND Dementia has become one of the leading causes of death across the world. OBJECTIVE The aim of this study was to investigate the incidence, prevalence, and mortality of dementia in China between 2010 and 2020, and to investigate any geographical, age, and sex differences in the prevalence and incidence of dementia. METHODS Five databases were searched. The Joanna Briggs Institute (JBI) critical appraisal tool was used to assess the quality of the included studies. A random-effects meta-analysis was performed to estimate the pooled prevalence of dementia. Subgroup analysis was based on the type of dementia. The incidence and mortality of dementia were synthesized qualitatively. RESULTS A total of 19 studies were included. The meta-analysis showed that the prevalence of dementia was 6% (95%CI 5%, 8%), the prevalence of Alzheimer's disease (AD) was 5% (95%CI 4%, 6%), and the prevalence of vascular dementia (VaD) was 1% (95%CI 0%, 2%). The subgroup analysis showed that the prevalence rates of dementia in rural (6%, 95%CI 4%, 8%) and urban areas were similar (6%, 95%CI 4%, 8%). Deaths due to dementia increased over time. CONCLUSIONS The prevalence, incidence, and mortality of dementia increased with age and over time. Applying consistent criteria to the diagnosis of cognitive impairment and dementia is necessary to help with disease monitoring. Promoting dementia knowledge and awareness at the community level is necessary.

UI MeSH Term Description Entries

Related Publications

Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
June 2013, Lancet (London, England),
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
January 2021, Annals of palliative medicine,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
November 2022, Human vaccines & immunotherapeutics,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
September 2021, PLoS neglected tropical diseases,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
December 2021, AIDS research and therapy,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
July 2022, Heliyon,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
September 2021, China CDC weekly,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
January 2021, Preventive veterinary medicine,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
January 2023, Diabetes research and clinical practice,
Yueheng Yin, and Hon Lon Tam, and Jennifer Quint, and Mengyun Chen, and Rong Ding, and Xiubin Zhang
September 2022, Orthopaedic journal of sports medicine,
Copied contents to your clipboard!